Plastic Surgery Intelligence Briefing
Robotic 3D bioprinter skin in situ, BREAST-II trial for fat-only breast reconstruction, novel monopolar RF RCT, AI mapping across five surgical domains.
Weekly Intelligence Briefing
Peer-reviewed research, new surgical techniques, regenerative medicine, aesthetic devices, and significant innovations — curated weekly for plastic and reconstructive surgeons.
This week’s evidence points to three practical shifts: reconstruction is becoming more protocolized and personalized, immune and biomaterial design are moving to the center of difficult-wound care, and exosome, device, and AI advances are outpacing the standardization needed for safe translation. The strongest near-term signals are the 5,671-flap microsurgical benchmark, a new immune-reprogramming frame for diabetic wounds, and a rapidly maturing but still low-certainty technology stack.
Read this issueThis Issue
Robotic 3D bioprinter skin in situ, BREAST-II trial for fat-only breast reconstruction, novel monopolar RF RCT, AI mapping across five surgical domains.
This week’s briefing spotlights new momentum in functional reconstruction (free-flap neurotization) and implant surveillance (a validated histologic method to q...
This week’s briefing highlights a novel extension of hemostatic-net quilting sutures for post–massive weight loss contouring, plus interim RCT data showing comp...
This week: the world's first living bioprinted ear cartilage implant advances to human trials, high-frequency ultrasound guidance lifts facial fat grafting sati...
Robotic microsurgery reaches a new milestone as the Synaptix+Symani digital overlay system demonstrates successful microvascular anastomosis in a pilot study, w...
This week’s literature highlights three converging themes: exosome-enabled wound therapeutics (smart, responsive hydrogels), renewed focus on post-op wound opti...
This week’s literature spotlights a randomized clinical trial suggesting copper-oxide dressings can be noninferior to NPWT for diabetic wounds (with major conve...
This week’s most actionable themes: (1) robotic microsurgery is consolidating into a clinically feasible workflow with high pooled flap-survival (still needs co...
A new systematic review and meta-analysis consolidates helium plasma radiofrequency data across 3,508 patients, reporting 92% satisfaction and a favorable safet...
Robotic-assisted microsurgery continues to mature—recent clinical syntheses report high free-flap survival, while DIEP cohorts suggest comparable complication r...
Robotic-assisted microsurgery continues to mature: recent evidence suggests comparable complication rates to conventional anastomosis with potential reductions ...
This week’s briefing highlights accelerating adoption of robotic assistance and AI across reconstructive microsurgery, alongside biomaterial-driven advances for...
A landmark 10-year bibliometric analysis maps the exponential rise of AI in plastic surgery, revealing that deep learning and robotic-assisted microsurgery are ...
Robotic microsurgery continues to move from feasibility toward broader adoption, with early pooled outcomes in head & neck reconstruction suggesting high flap s...
New 2026 work highlighted this week includes (1) a prospective breast reconstruction study suggesting supercritical CO2–processed acellular dermal matrix perfor...
Robotic-assisted microsurgical anastomosis is moving from novelty to pragmatic benefit in breast reconstruction, with early cohort data showing comparable compl...
A 206-patient randomized trial found hypothermically stored amniotic membrane plus standard care improved closure and wound-size outcomes in complex venous leg ...
This week's briefing spotlights a practical shift toward protocolized, data-informed care: ERAS pathways can shorten recovery after flap reconstruction without ...
This week's briefing centers on a pragmatic shift toward protocolized, personalized reconstruction: ERAS pathways and mucosal-lining restoration are linked to b...
This week’s evidence points to three practical shifts: reconstruction is becoming more protocolized and personalized, immune and biomaterial design are moving t...